NCT02363400 2025-08-19
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
National Health Research Institutes, Taiwan
Phase 3 Terminated
National Health Research Institutes, Taiwan
Institut Cancerologie de l'Ouest
Zhejiang Cancer Hospital
Fudan University
Fudan University
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Sun Yat-sen University
Hokkaido Gastrointestinal Cancer Study Group
West Japan Thoracic Oncology Group